Rebecca C Fitzgerald Selected Research

Cyclin A

6/2020	Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of Barrett's oesophagus: A multi-centre prospective cohort study.
11/2015	Autofluorescence-Directed Confocal Endomicroscopy in Combination With a Three-Biomarker Panel Can Inform Management Decisions in Barrett's Esophagus.
1/2015	The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus.
1/2007	Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance.
11/2004	Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rebecca C Fitzgerald Research Topics

Disease

47	Neoplasms (Cancer) 06/2022 - 06/2005
43	Adenocarcinoma 01/2022 - 07/2003
33	Barrett Esophagus (Barrett's Esophagus) 01/2022 - 03/2003
11	Carcinogenesis 12/2019 - 07/2004
10	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2006
5	Metaplasia 02/2022 - 07/2007
5	Aneuploidy (Aneuploid) 06/2020 - 01/2005
5	Carcinoma (Carcinomatosis) 07/2016 - 11/2004
4	Disease Progression 01/2022 - 02/2009
4	Gastroesophageal Reflux (GERD) 01/2020 - 10/2013
3	Obesity 01/2020 - 04/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 07/2016
3	Esophageal Neoplasms (Esophageal Cancer) 12/2013 - 02/2006
2	Inflammation (Inflammations) 01/2021 - 09/2005
2	Tetraploidy 06/2020 - 01/2015
2	Heartburn (Pyrosis) 01/2020 - 01/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2022
1	Genomic Instability 11/2021
1	Genetic Risk Score 11/2020
1	Pain (Aches) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Infections 12/2019
1	Mesothelioma 01/2019
1	Eosinophilic Esophagitis 01/2015
1	Signet Ring Cell Carcinoma 07/2014
1	Chest Pain (Chest Pains) 01/2014
1	Abdominal Pain (Pain, Abdominal) 01/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2013

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 02/2022 - 11/2007
9	AcidsIBA 07/2021 - 03/2003
7	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 06/2005
6	Cadherins (E-Cadherin)IBA 01/2018 - 01/2006
5	Biological ProductsIBA 01/2022 - 10/2013
5	Cyclin AIBA 06/2020 - 11/2004
4	MicroRNAs (MicroRNA)IBA 02/2022 - 12/2013
4	Trefoil Factor-3IBA 01/2022 - 01/2015
4	LectinsIBA 01/2018 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2019
3	GastrinsIBA 01/2021 - 12/2003
3	ChromatinIBA 01/2021 - 02/2009
3	ElementsIBA 01/2020 - 07/2015
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2003
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2010 - 10/2007
3	Transforming Growth Factor beta (TGF-beta)IBA 04/2010 - 01/2007
2	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2020 - 03/2016
2	Transcription Factors (Transcription Factor)IBA 08/2017 - 04/2012
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2017 - 02/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2013 - 05/2013
2	Phenobarbital (Luminal)FDA Link 09/2010 - 10/2007
2	CytokinesIBA 02/2010 - 09/2005
2	Histones (Histone)IBA 02/2009 - 11/2004
2	VimentinIBA 07/2007 - 10/2006
2	imidazole mustard (BIC)IBA 01/2007 - 09/2005
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2005 - 07/2004
2	Cyclin D1IBA 01/2005 - 11/2004
1	isooctyl acrylateIBA 06/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	Contrast MediaIBA 01/2022
1	Peptides (Polypeptides)IBA 11/2021
1	APOBEC-1 DeaminaseIBA 11/2021
1	Circulating Tumor DNAIBA 11/2021
1	AldehydesIBA 01/2021
1	Cholecystokinin B ReceptorIBA 01/2021
1	YF 476IBA 01/2021
1	NucleotidesIBA 11/2020
1	Trefoil FactorsIBA 08/2020
1	ParaffinIBA 03/2020
1	Formaldehyde (Formol)FDA Link 03/2020
1	Retroelements (Retrotransposon)IBA 01/2020
1	Biological FactorsIBA 01/2020
1	SugarsIBA 12/2019
1	gastrin 17 (G 17)IBA 12/2019
1	Pepsinogen A (Pepsinogen)IBA 12/2019
1	PlatinumIBA 11/2019
1	Vitamin D FDA LinkGeneric 10/2019
1	hydroxide ionIBA 10/2019
1	AsbestosIBA 01/2019
1	Capsules (Microcapsules)IBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Proton Pump InhibitorsIBA 01/2019
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 04/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	Prostaglandins DIBA 10/2017
1	human ERBB2 proteinIBA 07/2017
1	Trastuzumab (Herceptin)FDA Link 07/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2017
1	16S Ribosomal RNAIBA 01/2017
1	Genetic Markers (Genetic Marker)IBA 10/2016
1	AndrogensIBA 03/2016
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2015

Therapy/Procedure

17	Therapeutics 01/2022 - 02/2006
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
5	Gastrectomy 01/2020 - 07/2010
3	Radiofrequency Ablation 01/2022 - 01/2013
3	Neoadjuvant Therapy 07/2021 - 01/2017
2	Endoscopes 10/2021 - 01/2016
2	Esophagectomy 01/2014 - 01/2013
1	Optical Fibers 12/2019
1	Adjuvant Chemotherapy 04/2018
1	Chemoradiotherapy 07/2017